Approaches to refining estimates of global burden and economics of dengue
- PMID: 25412506
- PMCID: PMC4238988
- DOI: 10.1371/journal.pntd.0003306
Approaches to refining estimates of global burden and economics of dengue
Abstract
Dengue presents a formidable and growing global economic and disease burden, with around half the world's population estimated to be at risk of infection. There is wide variation and substantial uncertainty in current estimates of dengue disease burden and, consequently, on economic burden estimates. Dengue disease varies across time, geography and persons affected. Variations in the transmission of four different viruses and interactions among vector density and host's immune status, age, pre-existing medical conditions, all contribute to the disease's complexity. This systematic review aims to identify and examine estimates of dengue disease burden and costs, discuss major sources of uncertainty, and suggest next steps to improve estimates. Economic analysis of dengue is mainly concerned with costs of illness, particularly in estimating total episodes of symptomatic dengue. However, national dengue disease reporting systems show a great diversity in design and implementation, hindering accurate global estimates of dengue episodes and country comparisons. A combination of immediate, short-, and long-term strategies could substantially improve estimates of disease and, consequently, of economic burden of dengue. Suggestions for immediate implementation include refining analysis of currently available data to adjust reported episodes and expanding data collection in empirical studies, such as documenting the number of ambulatory visits before and after hospitalization and including breakdowns by age. Short-term recommendations include merging multiple data sources, such as cohort and surveillance data to evaluate the accuracy of reporting rates (by health sector, treatment, severity, etc.), and using covariates to extrapolate dengue incidence to locations with no or limited reporting. Long-term efforts aim at strengthening capacity to document dengue transmission using serological methods to systematically analyze and relate to epidemiologic data. As promising tools for diagnosis, vaccination, vector control, and treatment are being developed, these recommended steps should improve objective, systematic measures of dengue burden to strengthen health policy decisions.
Conflict of interest statement
This study was supported in part by a research agreement between Sanofi Pasteur and Brandeis University. This does not alter our adherence to all PLOS NTDs policies on sharing data and materials.
Figures
Similar articles
-
The global economic burden of dengue: a systematic analysis.Lancet Infect Dis. 2016 Aug;16(8):935-41. doi: 10.1016/S1473-3099(16)00146-8. Epub 2016 Apr 16. Lancet Infect Dis. 2016. PMID: 27091092
-
Disease and economic burdens of dengue.Lancet Infect Dis. 2017 Mar;17(3):e70-e78. doi: 10.1016/S1473-3099(16)30545-X. Epub 2017 Feb 7. Lancet Infect Dis. 2017. PMID: 28185869 Review.
-
Economic and disease burden of dengue in Mexico.PLoS Negl Trop Dis. 2015 Mar 18;9(3):e0003547. doi: 10.1371/journal.pntd.0003547. eCollection 2015 Mar. PLoS Negl Trop Dis. 2015. PMID: 25786225 Free PMC article.
-
Productivity costs from a dengue episode in Asia: a systematic literature review.BMC Infect Dis. 2020 Jun 3;20(1):393. doi: 10.1186/s12879-020-05109-0. BMC Infect Dis. 2020. PMID: 32493234 Free PMC article.
-
Tuberculosis.In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.
Cited by
-
The epidemiologic and economic burden of dengue in Singapore: A systematic review.PLoS Negl Trop Dis. 2024 Jun 10;18(6):e0012240. doi: 10.1371/journal.pntd.0012240. eCollection 2024 Jun. PLoS Negl Trop Dis. 2024. PMID: 38857260 Free PMC article.
-
Development of a tetravalent subunit vaccine against dengue virus through a vaccinomics approach.Front Immunol. 2023 Nov 17;14:1273838. doi: 10.3389/fimmu.2023.1273838. eCollection 2023. Front Immunol. 2023. PMID: 38045699 Free PMC article.
-
Enrollment of dengue patients in a prospective cohort study in Umphang District, Thailand, during the COVID-19 pandemic: Implications for research and policy.Health Sci Rep. 2023 Nov 8;6(11):e1657. doi: 10.1002/hsr2.1657. eCollection 2023 Nov. Health Sci Rep. 2023. PMID: 38028707 Free PMC article.
-
Assessing the burden of dengue among household members in Alaminos, Laguna, the Philippines: a prospective cohort study.Asian Biomed (Res Rev News). 2021 Oct 29;15(5):213-222. doi: 10.2478/abm-2021-0027. eCollection 2021 Oct. Asian Biomed (Res Rev News). 2021. PMID: 37551324 Free PMC article.
-
Analysis of dengue fever disease in West Africa.Exp Biol Med (Maywood). 2023 Oct;248(20):1850-1863. doi: 10.1177/15353702231181356. Epub 2023 Jul 15. Exp Biol Med (Maywood). 2023. PMID: 37452719 Free PMC article.
References
-
- TDR/WHO (2009) Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. New Edition. Geneva, Switzerland: Special Programme for Research and Training in Tropical Diseases (TDR); Department of Control of Neglected Tropical Diseases World Health Organization (WHO). pp. 160.
-
- Simmons CP, Farrar JJ, Nguyen VVC, Wills B (2012) Current concepts: Dengue. N Engl J Med 366: 1423–1432. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials